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The leader protein of cardioviruses, Theiler’s murine encephalomyelitis virus (TMEV) and encephalomyo-
carditis virus (EMCV), is a multifunctional protein known to antagonize type I interferon expression and to
interfere with nucleocytoplasmic trafficking of host proteins and mRNA. This protein plays an important role
in the capacity of TMEV to establish persistent infection of the central nervous system. Mutant forms of the
TMEV leader protein were generated by random mutagenesis and selected after retroviral transduction on the
basis of the loss of the highly toxic nature of this protein. Selected mutations define a short C-terminal domain
of the leader conserved in TMEV and Saffold virus but lacking in the EMCV leader and thus called the Theilo
domain. Mutations in this domain had a dramatic impact on TMEV L protein activity. Like the zinc finger
mutation, Theilo domain mutations affected all of the activities of the L protein tested: interferon gene
transcription and IRF-3 dimerization antagonism, alteration of nucleocytoplasmic trafficking, nucleoporin 98
hyperphosphorylation, and viral persistence in vivo. This suggests that the Zn finger and the Theilo domain
of the protein cooperate for function. Moreover, the fact that all of the activities tested were affected by these
mutations suggests that the various leader protein functions are somehow coupled.
Theiler’s murine encephalomyelitis virus (TMEV) is a neuro-
tropic picornavirus that belongs to the Cardiovirus genus (re-
viewed by Brahic et al. [5]). The leader (L) protein of TMEV is a
short (76 amino acids), very acidic protein. This protein helps the
establishment of persistent TMEV infections in the central ner-
vous system by antagonizing innate host defenses. It inhibits the
transcription of type I interferon (IFN) and selected cytokine and
chemokine genes, likely through inhibition of IRF-3 dimerization
(19, 25, 28, 33, 34). It also interferes with nucleocytoplasmic traf-
ficking of cellular proteins and blocks mRNA export from the
nucleus (11, 28). These activities correlate with the phosphoryla-
tion of nucleoporin 98 (Nup98) (28).
The sequence of the L protein contains three domains: a
zinc finger domain that was shown to bind divalent cations (7),
an acidic central domain, and a Ser/Thr-rich domain (see Fig.
2). The L protein encoded by encephalomyocarditis virus
(EMCV) shows 35% amino acid identity with the TMEV L
protein. In the EMCV L protein, the zinc finger and the acidic
domain are conserved but the C-terminal region encompassing
the Ser/Thr-rich domain is lacking. In spite of this difference, L
proteins of cardioviruses share the abilities to antagonize IFN
production, to affect nucleocytoplasmic trafficking of mRNA
and proteins, and to promote nucleoporin hyperphosphoryla-
tion (3, 16, 21, 25–27, 36).
Likely as a consequence of mRNA nuclear export inhibition,
the TMEV L protein mediates shutoff of host protein synthesis
and is very toxic when expressed in cells (2, 11, 28). In this
work, we took advantage of this toxicity to select L mutants
that lost the ability to shut off host protein synthesis in order to
identify critical domains of the L protein and to test whether
the multiple activities of the L protein can be uncoupled.
MATERIALS AND METHODS
Cells and viruses. BHK-21 cells were cultured as previously described (34).
BALB/3T3, L929, and Phoenix-Eco cells were cultured in Dulbecco’s modified
Eagle medium (Gibco) supplemented with 10% fetal bovine serum (MP Bio-
logicals), 100 IU of penicillin/ml, and 100 g of streptomycin/ml. Phoenix-Eco
cells were kindly provided by G. Nolan via the ATCC (SD-3444).
TMEV derivatives were produced by electroporation of BHK-21 cells (23)
with genomic RNA transcribed in vitro from plasmids carrying the corresponding
cDNAs. Virus DA1 was produced from plasmid pTMDA1 (10, 22, 23). Virus
TM598 is a DA1 derivative carrying mutations that disrupt the zinc finger motif
of the L protein (Zn mutation, previously referred to as an Lcys mutation) (34).
FB05, FB06, and FB07 are DA1 derivatives bearing the M60V, W62R, and T63A
mutations in the L coding region, respectively. Plasmids pFB05, pFB06, and
pFB07, carrying the corresponding viral cDNA, were obtained as follows. A
synthetic sequence made of annealed primers (TM896-TM897 for M60V,
TM898-TM899 for W62R, and TM900-TM901 for T63A) was used to replace the
segment of the L coding region between the unique XhoI and BsiWI restriction
sites of pTM410, a subclone carrying the 5 1,730 nucleotides of the DA1 virus
(31). Mutated L coding regions were then transferred into pTMDA1 derivates as
BbrPI-BsiWI fragments. KJ6 is a DA1 derivative containing capsid mutations
that adapt the virus to infect L929 cells with high efficiency (17). The corre-
sponding zinc finger mutant is called TM659 (34). SB3, another derivative of
KJ6, carries a deletion encompassing codons 6 to 67 of the L region (6-67) (28).
FB09, FB10, and FB11 are KJ6 derivatives bearing the M60V, W62R, and T63A
mutations, respectively. These viruses were obtained as described above for the
DA1 derivatives. KJ6 derivatives used at a multiplicity of infection of 2 PFU per
cell yielded nearly 100% L929 cell infection, as assessed by VP1 immunostaining
at 8 h postinfection (hpi) (data not shown).
* Corresponding author. Mailing address: Universite´ catholique de
Louvain, de Duve Institute, MIPA-VIRO 74-49, 74, Avenue Hip-
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Plasmid construction. Plasmids were constructed in the pcDNA3 vector back-
bone (Invitrogen), in which gene transcription is under the control of the cyto-
megalovirus (CMV) immediate-early promoter.
A series of plasmids was designed to express fusion proteins constructed
between the L variants and enhanced green fluorescent protein (eGFP). Plas-
mids pCER01, pCER02, and pCER03, encoding LWT-, LZn-, and L-eGFP
fusions, respectively, were described previously (28). Plasmids encoding the mu-
tant LM60V-, LW62R-, LT63A-, and LP66S-eGFP fusions were obtained by cloning,
into pCER01, the BamHI-BstEII mutated fragment of L amplified by PCR from
genomic DNA of the clones selected after random mutagenesis (see below for
the mutagenesis and mutant selection procedures used). To construct the T63D
mutant encoded by pCER58, the L region was PCR amplified from pCER01
derivatives with primers TM247 and TM904 and the BamHI-BsiWI segment of
the PCR product was cloned into pCER01. The 3D-3A mutant (D44A, D45A,
D46A) encoded by pCER31 was obtained by cloning, into pCER01, the BamHI-
XhoI fragment of the PCR product obtained after amplification of L with
primers TM245 and TM831. The 3S-3A mutant (S51A, S53A, S54A) encoded by
pCER35 was obtained by cloning, into pCER01, the BamHI-BsiWI fragment of
the PCR product obtained after amplification of L with primers TM245 and
TM832 (Table 1).
A second series of plasmids was designed to express the L variants alone: the
LWT, LZn, and L6-67 proteins are encoded by pTM553, pTM592, and pTM641,
respectively (28). The plasmids expressing the other mutant proteins were ob-
tained by replacing, in pTM533, the BamHI-BsiWI fragment of L with the
mutated fragment taken from the first series of plasmids (Table 1). A third series
of plasmids was derived from pTM625 (L-internal ribosome entry site [IRES]-
eGFP). These plasmids coexpress the L variants and eGFP (28). Plasmids
pTM626 and pTM624 express the LZn and L proteins, respectively (28). The
other L-IRES-eGFP constructs were obtained by cloning the mutated sequences
from the first plasmid series, as BamHI-BsiWI fragments, into pTM625. Table 1
summarizes the properties of the various L-expressing plasmids used in this
study. For cloning, PCR amplification was done with Pfu polymerase (Fermen-
tas). The primers used for PCR and mutagenesis are presented in Table 2.
Plasmid pCS41 is a pcDNA3 derivative expressing the firefly luciferase gene
(30). Plasmid pCER07 was derived from the retroviral vector pQCXIN (Clon-
tech). In this vector, the CMV promoter was replaced with a tetracycline-induc-
ible promoter (seven tet operators followed by a minimal CMV promoter) taken
from plasmid pUHD10-3 (14). Transcription from this promoter is activated by
the artificial rtTA transcription factor upon doxycycline addition (15). The
BstEII restriction site present in the GAG region of the vector was eliminated by
site-directed mutagenesis. The BamHI-XbaI fragment of pCER01 that encodes
the L-eGFP fusion was then cloned into the modified vector to yield pCER07.
TABLE 1. Plasmids carrying the viral cDNA of constructed mutants and plasmids expressing L protein variants
Mutation
Plasmid carrying viral cDNA Plasmid expressing L protein variant
WT capsid Capsid adaptedto L929 cells PCMV-L PCMV-L-eGFP
PCMV-L-IRES-
eGFP
None (WT) pTMDA1 pKJ6 pTM553 pCER01 pTM625
Zn/Lcysa pTM598 pTM659 pTM592 pCER02 pTM626
 (or 6-67)b pSB3 (6-67)b pTM641 (6-67)b pCER03 pTM624
M60V pFB05 pFB09 pCER44c pCER40c pCER48c
W62R pFB06 pFB10 pCER56c pCER50c pCER57c
T63A pFB07 pFB11 pCER45c pCER41c pCER49c
P66S pCER62c pCER61c pCER63c
T63D pCER59c pCER58c pCER60c
3D-3A pCER30 pCER31 pCER70
3S-3A pCER34 pCER35 pCER71
a The formerly named Lcys mutation was renamed the Zn mutation for clarity.
b 6-67 (where indicated), deletion of codons 6 to 67 of L. , complete deletion of L.
c Plasmid in which the first two AUG codons (codons 1 and 5) of the alternative L* open reading frame were changed to ACG without modification of the L amino
acid sequence.
TABLE 2. Primers used in this study
Name Sequence (533) Usea
TM245 (s) CTG GCT AAC TAG AGA ACC CA Mutagenesis
TM247 (s) TAA TAC GAC TCA CTA TAG GGA Mutagenesis
TM281 (s) ACC CGG GTC GAG GTA GGC GT amplification
TM595 (as) GGA CAC GCT GAA CTT GTG G Mutagenesis
TM687 (as) CGT CCA GCT CGA CCA GGA TG Amplification
TM831 (as) AAA GCT CGA GTT CGA AGG CCA GAA GAC GGC AGC GGC CAG GTC CAC
ACA AAG AAG
Mutagenesis
TM832 (as) AAA GCG TAC GAG CGG TAA GTC AGT CCA TTC CAT TGT TTC AGA TTG
ATT GGC CGC GTT CGC AGG CCA GAA GAC GTC ATC
Mutagenesis
TM896 (s) TCG AGC AAT CAA TCT GAA ACA GTG GAA TGG ACT GAC TTA CCG CTC Mutagenesis
TM897 (as) GTA CGA GCG GTA AGT CAG TCC ATT CCA CTG TTT CAG ATT GAT TGC Mutagenesis
TM898 (s) TCG AGC AAT CAA TCT GAA ACA ATG GAA CGG ACT GAC TTA CCG CTC Mutagenesis
TM899 (as) GTA CGA GCG GTA AGT CAG TCC GTT CCA TTG TTT CAG ATT GAT TGC Mutagenesis
TM900 (s) TCG AGC AAT CAA TCT GAA ACA ATG GAA TGG GCT GAC TTA CCG CTC Mutagenesis
TM901 (as) GTA CGA GCG GTA AGT CAG CCC ATT CCA TTG TTT CAG ATT GAT TGC Mutagenesis
TM904 (as) TAT CGC GTA CGA GCG GTA AGT CAT CCC ATT CCA TTG T Mutagenesis
TM346 (s) GCC GCT CTT CAC ACC CAT qPCR virus
TM347 (as) AGC AGG GCA GAA AGC ATC AC qPCR virus
TM425 (s) ACT CCC TGC TGC TTT GCC TA qPCR RANTES
TM426 (as) CCC ACT TCT TCT CTG GGT TGG qPCR RANTES
TM642 (s) ATG AAC AAC AGG TGG ATC CTC C qPCR IFN-
TM643 (as) AGG AGC TCC TGA CAT TTC CGA A qPCR IFN-
a qPCR, quantitative PCR.
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Random mutagenesis and mutant selection (see Fig. 1). Mutagenic PCR was
performed with primers TM247 and TM595 on pCER24, a variant of pCER01 in
which the L* putative initiation codons were replaced with ACG codons. Error-
prone PCR conditions included an imbalanced proportion of deoxynucleoside
triphosphates (dCTP and dTTP at 0.5 mM and dGTP and dATP at 0.2 mM), the
use of a Taq polymerase lacking 3–5 exonuclease activity (aTaq; Promega), and
a high number (n  35) of amplification cycles. The BamHI-BstEII fragment of
the PCR product pool was cloned into the pCER07 retroviral vector, in frame
with eGFP and under the control of the tetracycline-inducible promoter. A
mutated L-eGFP retrovirus library was then produced by transfecting the pool of
constructs into Phoenix-Eco cells by calcium phosphate transfection. Retro-
viruses were collected from the supernatant of the packaging cells 24 h post-
transfection and used to transduce BALB/3T3-rtTA cells which stably express
the tetracycline-activated rtTA transcription factor. Two days after transduction,
expression of the L-eGFP constructs was induced with 5 g/ml doxycycline.
Three days after the addition of doxycycline, eGFP-expressing cells were sorted
by flow cytometry (FACS Vantage; Becton Dickinson) and cloned in 96-well
plates. Cells were sorted as FL1-positive and FL2-negative cells to minimize
contamination by autofluorescent cells. The sorted cell population represented
about 0.02% of the total cells. After 10 to 21 days of growth, genomic DNA of
growing cell clones was extracted by boiling the cells at 100°C for 20 min. The L
coding region was PCR amplified from these samples (Taq polymerase from
Biotools) with primers TM687 and TM281, and PCR products were sequenced.
DNA transfection of BALB/3T3 cells and functional L testing. Plasmid DNA
was transfected with TransIT-LT1 transfection reagent (Mirus) according to the
manufacturer’s recommendations. We used 1.5 to 3 l of transfection reagent
with 0.5 to 1 g of DNA to transfect about 300,000 cells grown in a well of a
24-well plate.
Lactate dehydrogenase (LDH) assay (Roche) was performed on the superna-
tant of BALB/3T3 cells transfected for 48 h with pcDNA3 derivatives expressing
the L protein variants alone.
Inhibition of firefly luciferase expression (Luciferase Reporter Gene Assay;
Roche) by L protein was assessed 7 h after cotransfection of BALB/3T3 cells with
100 ng of pCS41 and 400 ng of the pcDNA3 derivatives expressing the L protein
variants.
Fluorescence-activated cell sorter analysis of eGFP mean fluorescence inten-
sity was performed on BALB/3T3 cells 24 h after the transfection of plasmids
expressing wild-type (WT) and mutated L-eGFP fusion proteins.
Localization of the mRNA pool in the cell was performed by oligo(dT)-probed
in situ hybridization as described previously (6, 28).
Polypyrimidine tract binding protein (PTB) was localized in infected cells by
indirect immunofluorescence as described by Paul and Michiels (25).
IRF-3 dimerization and Nup98 immunoblotting. L929 cells were infected with
2 PFU per cell of WT or L mutant KJ6 derivatives or mock infected. IRF-3
dimerization was assessed as described previously (16).
Nup98 immunoblotting was performed as described by Park et al. (24). Briefly,
at indicated times, crude cell lysates were harvested in Laemmli buffer and equal
amounts of lysates were resolved on an 8% sodium dodecyl sulfate-polyacryl-
amide gel, transferred to a polyvinylidene fluoride membrane, and subjected to
Western blot analysis with a rat anti-Nup98 antibody (2H10; Sigma Aldrich) used
at 1/1,000 and an anti-rat antibody coupled to horseradish peroxidase (Dako). As
a loading control, -actin was detected with a mouse anti--actin monoclonal
antibody (AC-15; Sigma Aldrich) used at 1/2,000 and a secondary anti-mouse
antibody coupled to horseradish peroxidase (Dako). The signal was detected by
chemiluminescence (Supersignal; Pierce).
Mice and infections. Female 3-week-old FVB/N mice were purchased from
Charles River Laboratories. Handling of mice and experimental procedures were
conducted in accordance with national and institutional guidelines for animal
care and use. Infections were initiated in mice by intracranial injection of 40 l
of serum-free medium containing 105 PFU of the indicated virus derived from
the DA1 strain. Control mice were injected with 40 l of serum-free culture
medium. At 45 days postinfection, total RNA was extracted from the spinal cords
of infected mice as previously described (25).
Real-time quantitative reverse transcription (RT)-PCR. Total RNA prepara-
tions, RT, and real-time PCRs were performed as previously described (25). The
sequences of the primers used are shown in Table 2.
RESULTS
Selection of randomly generated L mutants lacking cytotox-
icity by retrovirus-mediated transduction. We and others pre-
viously observed that L expression was cytotoxic (2, 28). Owing
FIG. 1. Strategy used to select L protein mutants lacking toxicity.
Random mutagenesis was performed by error-prone PCR amplification
of the L protein coding region. The PCR product was cloned into a
retroviral vector as a BamHI-BstEII fragment to generate a library of
mutant L sequences cloned in frame with the eGFP coding sequence. In
these constructs, transcription of the L-eGFP fusion is driven by a tetra-
cycline-inducible promoter. BALB/3T3-rtTA cells transduced with the
constructs were treated with doxycycline to induce expression of the L-
eGFP fusion. Only cells expressing a nontoxic mutant L-eGFP fusion are
expected to be eGFP positive and able to grow. Thus, transduced cells
were sorted for green fluorescence by flow cytometry and cloned. After
growth, genomic DNA was extracted from cellular clones and the L
coding sequence was PCR amplified and sequenced to identify mutations
that abrogated L protein toxicity. LTR, long terminal repeat.
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to this toxicity, in spite of many efforts, all of our attempts to
generate stably transfected or transduced cells expressing L or
L-eGFP constructs were unsuccessful (data not shown). Here,
we exploited this toxicity of L-eGFP fusions to select nontoxic
L mutants after random mutagenesis of the L moiety of the
construct.
To limit the selection of frameshift mutations, mutagenic
PCR was performed on an L coding sequence lacking the two
potential initiation codons present in the L* reading frame
which overlaps the L coding region (29, 32). The PCR product
was cloned in frame with eGFP, under the control of a tetra-
cycline-inducible promoter, into a retroviral vector (Fig. 1). A
retroviral vector library carrying the mutated L-eGFP fusions
was thus generated and used to transduce BALB/3T3-rtTA
cells stably expressing the tetracycline-inducible rtTA tran-
scriptional activator. Two days after transduction, L-eGFP
gene expression was induced by treatment of the cells with 5
g/ml doxycycline for 72 h. Cells displaying green fluorescence
were sorted by flow cytometry and cloned (Fig. 1). Only cells
transduced with the construct were expected to display green
fluorescence. On the one hand, cells receiving a WT L-eGFP
construct or a construct carrying mutations that failed to affect
L toxicity were expected to die and thus to be counterselected.
On the other hand, stop codon or frameshift mutations in the
L moiety of the fusion were expected to prevent eGFP expres-
sion. Thus, growing cells expressing eGFP were expected to
carry mutations that eliminated L toxicity. After growth, the L
coding region of such clones was PCR amplified from genomic
DNA and sequenced.
L coding regions could be amplified from 74 out of 145
growing clones. Twenty-one mutants with different L se-
quences were obtained (Tables 3 and 4). That the mutagenesis
procedure was saturating or close to saturation was suggested
by the facts that (i) several identical mutants were selected
from two independent mutagenesis experiments and (ii) mu-
tations in a single codon (M60) yielded selected mutants with
four different coding capacities: T, L, V, and I. Interestingly, all
of the selected mutations clustered in the C-terminal part of
the L sequence, between codons M60 and M73 (Fig. 2 and
Table 3). Six of the 21 mutants possessed more than one
mutation, but at least one of these mutations was located in the
M60-to-M73 domain (Table 4). This C-terminal domain of the
TMEV L sequence is conserved in viruses from the Theilovirus
group but is lacking in the EMCV L sequence. We thus pro-
pose to name this domain the Theilo domain (Fig. 2).
Selected mutations in the C-terminal Theilo domain of L
impair L-mediated inhibition of mRNA export and shutoff of
host cell protein expression. The M60V, W62R, T63A, and
P66S mutations were selected for further analysis. The M60V
and W62R mutations were selected because cells expressing
the corresponding L-eGFP fusions exhibited high fluorescence
intensity and fair morphology, suggesting minimal L toxicity.
The T63A mutation was selected because it affected a Thr
residue that corresponded to a potential phosphorylation site.
However, the selected cell clone harboring this mutation grew
very poorly, suggesting that this mutation only partly affected L
activity. Additional mutations, generated by site-directed mu-
tagenesis, were included in the analysis (outlined in dark gray
in the L sequence shown on Fig. 2). These included (i) the zinc
finger mutation obtained previously (34); (ii) the 3D-3A mu-
tation obtained by substituting Ala residues for Asp residues
D44, D45, and D46; (iii) the 3S-3A mutation obtained by
substituting Ala residues for Ser residues S51, S53, and S54;
and (iv) the potential phosphomimetic mutation of T63
(T63D) (Fig. 2).
To characterize the impact of the selected mutations on the
activities of the L protein, the various mutated L sequences
were introduced into the pcDNA3 vector, allowing expression
of the L protein alone (pcDNA3 series); into the same vector
as an L-eGFP fusion protein (L-eGFP series); or as a bicis-
tronic construct, allowing coexpression of L and eGFP (L-
IRES-eGFP series) (Table 1).
As a first clue that L mutants selected after random mu-
tagenesis also lost toxicity when expressed without eGFP, the
pcDNA3 derivatives expressing L variants alone were trans-
TABLE 3. Selected single mutations
Position and
amino acid
change
Nucleotide change na
M60
M60L ATG3TTG 1
M60V ATG3GTG 2  2
M60T ATG3ACG 1  1
M60I ATG3ATT 5
E61, E61G GAA3GGA 2
W62, W62R TGG3CGG 2  2
T63
T63A ACT3GCT 1
T63P ACT3CCT 4
L65, L65*b TTA3TAA 3  4
P66
P66S CCG3TCG 1
P66L CCG3CTG 3  2
D70
D70G GAT3GGT 4  1
D70E GAT3GAG 4
M73, M73T ATG3ACG 6
a n n means that the mutation was obtained in two independent mutagenesis
experiments.
b  stands for the stop codon. It is not clear how this mutation yielded eGFP-
positive clones. We hypothesize that insertion of the stop codon at this position
might induce translation reinitiation at AUG 73.
TABLE 4. Selected multiple mutations
Amino acid changesa n
K4N, R69H, M73K ...................................................................................1
Y7N, L38L, P66S ......................................................................................1
A16G, E32G, E58N, V68E......................................................................1
D18V, P66L ...............................................................................................1
L26*, L67P .................................................................................................3
W49G, M60T .............................................................................................4
E61*, T63T.................................................................................................3
a  stands for the stop codon. It is not clear how this mutation yielded eGFP-
positive clones. We hypothesize that insertion of the stop codon at this position
might induce translation reinitiation at AUG 73. Underlined changes occur in
the defined Theilo domain.
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fected into BALB/3T3 cells and the toxicity of the mutants was
tested by measuring LDH activity in the supernatant of trans-
fected cells. As expected, all of the mutants selected after
random mutagenesis displayed reduced toxicity. Of the mu-
tants constructed, the 3S-3A mutant showed intermediate tox-
icity, while the T63D mutant retained WT toxicity (Table 5).
Shutoff of protein expression by the L protein was quantified
either by measuring the mean fluorescence intensity of cells
transfected with the L-eGFP fusion-expressing constructs or by
measuring inhibition of luciferase activity in cells cotransfected
with pCS41 and the pcDNA3 derivatives expressing the L
variants (Fig. 3A and B).
L protein inhibition of mRNA export from the nucleus was
measured, by in situ hybridization with an oligo(dT) probe, for
cells transfected with plasmids coexpressing the L variants and
eGFP (Fig. 3C).
Interestingly, the M60V, W62R, and P66S mutations that
were selected after random mutagenesis had a profound im-
pact on the L activities tested. These mutations completely
prevented L-mediated inhibition of luciferase or eGFP expres-
sion and dramatically reduced L-mediated mRNA nuclear ex-
port inhibition. Mutations 3D-3A and T63A had an interme-
diate, yet important, impact on L activity, as did the previously
characterized mutation of the Zn finger. Interestingly, muta-
tion of the Thr 63 residue into the phosphomimetic Asp resi-
due (T63D) fully restored L activity, suggesting that phosphor-
ylation of this residue might indeed regulate L protein activity,
as was suggested for the T47 residue of the EMCV L protein
(36). Surprisingly, mutation of the Ser cluster (3S-3A mutant)
had little impact on L activity, although this cluster is well
conserved among TMEV strains. Taken together, our data
show that mutations selected after random mutagenesis, more
noticeably, mutations M60V, W62R, and P66S, targeted a crit-
ical domain of the L protein required for inhibition of mRNA
export and for shutoff of protein expression.
To check whether the Theilo domain extends to residue
M73, as was defined by mutagenesis and sequence alignments
(Fig. 2), we tested the influence of the C-terminal D70G,
D70E, and M73T mutations by using the inhibition of lucifer-
ase expression assay. Luciferase activities in cells transfected
with these mutants were 120%  8% (D70G), 114%  19%
(D70E), and 130%  12% (M73T) of that measured in cells
transfected with the 6-67 mutant, which was taken as a ref-
erence. In this series of experiments, the luciferase activity was
8%  1% for the WT, 131%  21% for M60V, and 123% 
4% for W62R. The impact of the D70G, D70E, and M73T
mutations on L protein activity was thus close to that of the
M60V and W62R mutations.
Influence of selected L mutations in the context of viral
infections. To test whether the Theilo domain mutations also
affected other functions of the L protein such as the inhibition
of cytokine and chemokine gene transcription, the perturba-
tion of nucleocytoplasmic protein trafficking and viral persis-
tence in vivo, mutations M60V, W62R, and T63A were intro-
duced into the viral genome. These mutations were chosen
because (i) they greatly affected L activity (M60V and W62R),
(ii) they could be inserted into the viral genome without af-
fecting the amino acid sequence of the L* protein encoded by
an overlapping alternative reading frame, and (iii) they were
distant (positions 16, 14, and 13, respectively) from the
L/VP4 cleavage site of the viral polyprotein and were thus not
FIG. 2. Alignment of Cardiovirus L protein sequences and positions of selected mutations. Position of the domains defined in the L sequences
are indicated above the alignment. Mutations of the L sequence of the DA1 TMEV strain are indicated: mutations selected after random
mutagenesis for the loss of L toxicity are encircled in light gray. The 14 residues forming the Theilo domain are shown in bold characters in the
DA1 sequence and framed. Among these, the Thr corresponding to a putative phosphorylation site is indicated. Residues mutated in the Zn,
3D-3A, and 3S-3A mutants are outlined. The extent of the 6-67 deletion is shown under the sequence.
TABLE 5. LDH activity in the culture medium of BALB/3T3 cells
transfected with L-expressing plasmids
Expressed
L variant
LDH activitya
(mean  SD)
WT...........................................................................................3.19  0.19
Zn ............................................................................................1.16  0.44
6-67 .......................................................................................1.00  0.17
M60V ......................................................................................1.02  0.23
W62R ......................................................................................1.06  0.57
T63A .......................................................................................1.38  0.53
T63D .......................................................................................3.25  0.34
P66S.........................................................................................1.17  0.16
3D-3A......................................................................................1.51  0.12
3S-3A.......................................................................................3.19  1.04
a LDH activity was measured in the culture supernatant of BALB/3T3 cells
transfected for 72 h with pcDNA3 derivatives expressing the constructs indicated.
Activity was measured in six samples and standardized to that of the 6-67
construct.
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expected to affect this cleavage. These mutations were intro-
duced into plasmids carrying the genomes of viruses DA1
(WT) and KJ6, a DA1 derivative adapted to infect L929 cells
with high efficiency (17). The corresponding viruses were pro-
duced and titrated on BHK-21 cells in parallel with the WT
virus and with the previously constructed Zn and 6-67 mu-
tants. In BHK-21 cells, which are reportedly deficient in type I
IFN production, L mutant viruses formed plaques that were
similar in size to those formed by their respective parental
strains (DA1 and KJ6). KJ6 derivatives were also tested for
plaque formation on IFN-proficient L929 cells. On the latter
cells, KJ6 (WT) and FB11 (T63A) formed medium-size
plaques; TM659 (Zn), FB09 (M60V), and FB10 (W62R)
formed small plaques; and SB3 (L6-67) formed minute
plaques. These observation suggest that the L mutations
tested, with the exception of the T63A mutation, affected the
IFN antagonist activity of the L protein.
Replication of the mutated viruses in single-cycle L929 cell
infection, as measured by real-time RT-PCR, was similar to
that of the WT virus (Fig. 4A). Western blot analysis per-
formed on infected L929 cell extracts confirmed that L protein
expression and processing were WT for the M60V and T63A
mutants. In the case of the W62R mutant, the amount of
mature L protein detected by Western blot analysis was re-
duced, suggesting incomplete processing and/or protein insta-
bility (Fig. 4E). Alternatively, this mutation might have de-
creased the affinity of the antibody for the L protein.
As shown in Fig. 4B and C, the M60V and W62R point
mutations dramatically affected the ability of the virus to block
IFN- or RANTES gene transcription and, accordingly, to
inhibit IRF-3 dimerization (Fig. 4F). The effect of these two
mutations was almost as important as that of the 6-67 dele-
tion and much more prominent than that of the T63A muta-
tion. For most of the phenotypes tested, the Zn mutation
appeared to be less effective than the M60V and W62R mu-
tations.
Perturbation of nucleocytoplasmic trafficking, as measured
by the cytoplasmic redistribution of the nuclear PTB, was also
reduced strongly for the M60V and W62R mutant viruses, to a
lesser extent for the Zn mutant, and hardly, if at all, for the
T63A mutant (Fig. 5).
The L proteins of both EMCV and TMEV were recently
shown to trigger hyperphosphorylation of nucleoporins (3, 27,
28). Influence of L mutations on Nup98 phosphorylation par-
alleled the effect observed for the other phenotypes. Infection
of L929 cells with KJ6 (LWT) strongly induced Nup98 phos-
phorylation, which peaked at 6 to 8 hpi (Fig. 6A). Nup98
phosphorylation was detectable at 6 and 8 hpi in cells infected
with the T63A mutant (although to a much lesser extent than
in the case of the WT virus) and not detectable in cells infected
with the M60V and W62R mutants (Fig. 6B and data not
shown).
Finally, we checked the ability of the mutants to persist in
the spinal cords of infected FVB/N mice. Viral loads were
measured by real-time RT-PCR in spinal cord RNA samples
collected 45 days postinfection. As expected, the M60V and
W62R mutations affected viral persistence, as did the Zn mu-
tation. Viruses carrying the T63A mutation were less attenu-
ated and only exhibited a moderate decrease in viral load
compared to the WT virus (Fig. 7).
FIG. 3. Effects of transiently expressed mutated L proteins on
reporter gene expression and on mRNA export from the nucleus.
(A) Inhibition of L-eGFP expression by the L moiety of the fusion
protein: eGFP mean fluorescence intensity was measured in BALB/
3T3 cells 24 h after transfection of the constructs expressing L-
eGFP fusions. Histograms show the means and standard deviations
of fluorescence intensities measured in eGFP-positive cells, normal-
ized to the average of the control value (L mutant). Shown is a
representative experiment done in triplicate. (B) Inhibition of lu-
ciferase expression by mutant L proteins: luciferase activity was
measured in BALB/3T3 cells 7 h after cotransfection of pCS41
(expressing luciferase) and the L protein expression plasmids indi-
cated (pcDNA3 series). Histograms show the means and standard
deviations of the relative luciferase activities normalized to the
average of the control value (L6-67 mutant). Since no internal
standard for transfection efficiency was available, the experiment
was repeated several times with at least two different plasmid DNA
batches for each sample. Shown are the data for a representative
experiment done in triplicate. (C) The effect of L mutants on
mRNA export from the nucleus was examined by in situ hybridiza-
tion with an oligo(dT) probe in BALB/3T3 cells transfected for 16 h
with the L-IRES-eGFP plasmids. Histograms show the percentage
of eGFP-positive cells exhibiting mRNA nuclear retention, as as-
sessed by confocal microscopy. Counts for one representative ex-
periment out of three are presented. RLU, relative light units.
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Important viral load variation from mouse to mouse sug-
gested the emergence and selection of revertant viruses that
regained a functional L protein. However, sequencing of viral
L coding regions that were RT-PCR amplified from spinal cord
RNA samples confirmed the nature of the infecting viruses and
failed to reveal the presence of revertants.
DISCUSSION
We used random mutagenesis and a retrovirus transduction
strategy to select TMEV L protein mutants that lost their
toxicity. Although mutations were selected by using an L-eGFP
fusion, selected mutations also impaired L protein function
when expressed without eGFP or when introduced back into
the viral genome. The screening strategy appeared to be very
FIG. 4. Influence of L mutations in the context of viral infections.
L929 cells were mock infected (NI) or infected with 2 PFU per cell of
KJ6 derivatives expressing the WT L protein or the mutant L proteins
indicated. (A to C) Viral RNA, IFN- mRNA, and RANTES mRNA
levels measured at 9 hpi by real-time RT-PCR and normalized to the
amount of -actin mRNA for each sample. Histograms show the
means and standard deviations of relative RNA amounts for a tripli-
cate infection experiment. (D) PTB detection by immunofluorescence
in L929 cells infected for 5 h. Histograms show counts of cells showing
redistribution of PTB to the cytoplasm (images are shown in Fig. 6).
(E) Western blot analysis showing L protein and -actin (control)
detection in L929 cells at 16 hpi. (F) Western blot analysis of a non-
denaturing gel showing IRF-3 dimer formation in infected L929 cells
9 hpi with the indicated viruses or 7 h after poly(I:C) transfection
(pIC).
FIG. 5. PTB distribution in infected cells. PTB localization was
examined by immunofluorescence in L929 cells infected for 5 h with
WT and L mutant KJ6 derivatives. Cell nuclei were stained with
Hoechst 33258. NI, mock infected.
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efficient, as it allowed the identification of point mutations that
turned out to have a major impact on the L protein functions
tested, including viral persistence.
Interestingly, selected mutations clustered in a 14-amino-
acid region that defines a new functional domain of L, close to
the C terminus of the protein. This was unexpected because
this domain is not conserved in the L proteins of EMCV
strains. It was also surprising that the screening procedure
failed to yield zinc finger mutations, as mutations in this do-
main are known to have a major influence on L function (26,
27, 34, 36). However, we observed previously that the Zn
mutant had some residual activity (28) and we believe that this
residual activity might keep L toxicity too high to allow its
stable expression in cells. Among the mutations selected after
random mutagenesis, only the T63A mutation had a residual
activity that was comparable to or even higher than that of the
Zn mutant (Fig. 3). On the one hand, the cell clone expressing
this T63A mutant was moribund when collected after the
screening procedure; possibly, this cell clone also expressed
very low amounts of the protein. On the other hand, this
mutation had a greater relative impact on L protein activity
when expressed by transfection than when expressed in the
viral context (compare Fig. 3 and 4).
Among the mutations tested, M60V, W62R, and P66S
showed the most dramatic effect on L protein functions. This
effect was more pronounced than that of the zinc finger mu-
tation or that of the 3D-3A mutation, affecting three conserved
acidic residues of the central domain of the protein. Thus, our
mutants define a new domain of the protein that is critically
important for function. This domain, extending from M60 to
M73, is highly conserved in all of the TMEV strains sequenced
to date (Fig. 2). Interestingly, in spite of some variation up-
stream of M60, the defined domain is also conserved in the
recently described strains of Saffold virus (1, 4, 8, 12, 18, 20,
35), a highly prevalent human Cardiovirus related to TMEV
(alignment in Fig. 2). However, this domain is lacking in the
EMCV L protein. Thus, the identified cluster forms an extra
microdomain conserved in Theilovirus L proteins but lacking in
the EMCV L protein. Accordingly, we called this domain the
Theilo domain.
A goal of this work was to test whether the various functions
defined for the TMEV L protein are coupled. It is striking that
mutations in the Theilo domain affected all of the functions of
the L protein tested. In view of the strongly diverging physi-
cochemical properties of tryptophan and arginine, the W62R
mutation could well affect the overall folding of the protein. In
contrast, the M60V mutation is not expected to modify the
global folding of the protein. This mutation failed to affect
FIG. 6. Phosphorylation of Nup98 in cells infected with L mutant
viruses. Lysates from L929 cells infected with 2 PFU per cell of L
mutant KJ6 derivatives were analyzed by Western blot analysis to
determine the phosphorylation state of Nup98. (A) Kinetics of Nup98
phosphorylation in L929 cells infected with KJ6 (LWT). (B) Nup98
detection in cell lysates taken at 8 hpi with the indicated mutant KJ6
derivatives. The band detected at a higher molecular weight likely
corresponds to the 186-kDa precursor of Nup98 and Nup96 (13).
-Actin was detected as a loading control. NI, mock infected.
FIG. 7. Persistence of L mutant viruses in vivo. Viral RNA levels detected by real-time RT-PCR in the spinal cords of FVB/N mice infected
for 45 days with 105 PFU of the DA1 virus derivatives indicated. Columns show the results for individual mice. ND, not detected; NI, mock infected.
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virus infectivity and L protein production or stability (Fig. 4E).
Yet, the M60V mutation profoundly impacted all of the L
protein activities tested. On the other hand, the mutation that
affects the Zn finger of the protein also impairs these functions.
This suggests that the activity of the L protein depends on the
cooperation of its N- and C-terminal domains. Resolution of
the Cardiovirus L protein three-dimensional structure, which is
in progress (9), will be valuable in the further interpretation of
the data.
The data also suggest that activities as seemingly unre-
lated as transcriptional inhibition of cytokine genes and
hyperphosphorylation of nucleoporins might be connected.
Indeed, none of the mutations clearly allowed the uncou-
pling of L protein phenotypes. Influence of the Zn mutation
on mRNA export inhibition was relatively modest compared
to its effect on cytokine expression. However, it is not clear
whether such small differences reflect functional specificities
of the Zn finger and of other domains of the proteins or
whether they simply reflect sensitivity differences in the
functional tests that were used.
In conclusion, mutations selected after random mutagenesis
define a new domain of the Theiler’s virus L protein that is
critical for activity. This domain likely cooperates with the Zn
finger domain of the protein to accomplish the many activities
of the protein, which appear to be connected. Since this do-
main is conserved in the L protein of Saffold virus, it can be
anticipated that the critical residues defined in this work would
represent excellent targets for Saffold virus attenuation with
the prospect of producing a vaccinal strain.
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